Related Experiment Video
Updated: Jun 2, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
[Allergic bronchopulmonary aspergillosis. A review of 3 cases]
Leila Fekih1, Leila Boussoffara, Hajer Ben Abdelghaffar
1Hopital Abderrhmane MAMI de L'ARIANA, Tunisie.
Background:
Allergic bronchopulmonary aspergillosis (ABPA) is a rare affection, initially described in 1952. Its pathophysiology incriminate several mechanisms in relation with the organism of the patient and the bronchial colonisation by the fongic agent.
Aim:
To report three cases of ABPA.
Cases Report:
Three patients had been treated for ABPA in Ibn Nafiss department in Abderrahmen Mami hospital in Ariana. ABPA had been discovered in the three cases by a cortico dependant asthma, refractory for different therapeutics. Positive diagnosis reposed in the 3 patients at 6 major and one minor criterion. Treatment was essentially based in corticotherapy.
Conclusion:
Positive diagnosis of ABPA is actually well established, however, its treatment, although based on corticotherapy, remind not clearly codified. Association of antifongic treatment may improve the prognosis.
Insights
Allergic bronchopulmonary aspergillosis (ABPA) is a rare fungal lung disease. While diagnosis is established, treatment with corticosteroids needs clearer guidelines, and antifungals may improve outcomes.
Area of Science:
- Pulmonology
- Infectious Diseases
- Allergy & Immunology
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is a rare pulmonary disease.
- Pathophysiology involves host-fungus interactions in bronchial colonization.
Observation:
- Three cases of ABPA presented with corticosteroid-dependent asthma refractory to treatment.
- Diagnosis was confirmed using established major and minor criteria.
Findings:
- Corticosteroid therapy is the primary treatment for ABPA.
- Established diagnostic criteria aid in identifying ABPA.
Implications:
- While ABPA diagnosis is clear, treatment protocols require further codification.
- Combining antifungal therapy with corticosteroids may enhance patient prognosis.
Related Concept Videos
Asthma III: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
